Novel potent antiplatelet thrombotic agent derived from biguanide for ischemic stroke.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2020.112462
Abstract: Platelet thrombosis is the main pathogeny resulting in the low curability of ischemic stroke, a leading cause of mortality and disability worldwide. Metformin, a biguanide derivative that is the first-line oral medicine for type 2… read more here.
Keywords: ischemic stroke; novel potent; potent antiplatelet; platelet ... See more keywords